Home > NRC Library > ADAMS Public Documents

06-28799-01 611445 Alexion Pharmaceuticals, Inc.

Accession Number: ML19059A277

Date Released: Tuesday, April 2, 2019

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML19059A278 - Alexion Pharmaceuticals, Inc.; License Termination Request Letter dated 02/15/19. (55 page(s), 2/15/2019)
• ML19072A212 - Alexion Pharmaceuticals, Inc.; Deficiency Request E-mail dtd March 07, 2019; Control No. 611445. (1 page(s), 3/7/2019)
• ML19072A226 - Alexion Pharmaceuticals, Inc.; Deficiency Response NRC Form 314 - Certificate of Disposition of Materials - Termination Request; Control No. 611445. (2 page(s), 3/7/2019)
• ML19080A174 - Alexion Pharmaceuticals, Inc.; Additional Deficiency Request E-mail dtd March 13, 2019; Control No. 611445. (2 page(s), 3/13/2019)
• ML19084A280 - Alexion Pharmaceuticals, Inc., Deficiency Response Ltr. Dated March 18, 2019. (1 page(s), 3/18/2019)
• ML19092A412 - Alexion Pharmaceuticals, Inc., License Termination, Mail Control No. 611445. (3 page(s), 3/27/2019)
• ML19092A413 - Alexion Pharmaceuticals, Inc., Licensee Amendment No. 22, Mail Control No. 611445. (1 page(s), 3/27/2019)